PE
RGEN icon

Point72 Europe’s Repligen RGEN Stock Holding History

Point72 Europe’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$127K Buy
+952
New +$116K 0.01% 248

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Point72 Europe's RGEN Position: Q3 2025 in Review

Point72 Europe opened a new position in Repligen (RGEN) in Q3 2025: 952 shares worth $127K. The stake represents 0.01% of the portfolio and ranks #248 among its holdings.

451 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Point72 Europe held 952 shares of Repligen worth $127K as of Q3 2025.
  • Repligen was a new Point72 Europe position in Q3 2025.
  • Repligen made up 0.01% of Point72 Europe's portfolio in Q3 2025, its #248 holding.
  • 451 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.